Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Albiruni Ryan Abdul Razak

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Lung Cancer (Amsterdam, Netherlands)|October 18, 2008
Carboplatin and pemetrexed in the management of malignant pleural mesothelioma: a realistic treatment option?Louise Li, Albiruni Ryan Abdul Razak, Andrew Hughes
Lung Cancer (Amsterdam, Netherlands)|October 9, 2007
Retreatment with pemetrexed-based chemotherapy in malignant pleural mesothelioma (MPM): a second line treatment optionAlbiruni Ryan Abdul Razak, Katy J Chatten, Andrew N Hughes
Therapeutic Advances in Medical Oncology|May 15, 2024
Clinical activity of pembrolizumab in refractory <i>MDM2</i>-amplified advanced intimal sarcomasMauricio Fernando Ribeiro, Elizabeth G Demicco, Albiruni Ryan Abdul Razak
The Cochrane Database of Systematic Reviews|March 18, 2011
Chemotherapy for malignant germ cell ovarian cancer in adult patients with early stage, advanced and recurrent diseaseAlbiruni Ryan Abdul Razak, Louise Li, Andrew Bryant, et al.
Journal of Neuro-Oncology|June 4, 2005
Medulloblastoma in two successive pregnanciesAlbiruni Ryan Abdul Razak, Qasiem Nasser, Patrick Morris, et al.
Medgenmed : Medscape General Medicine|December 20, 2007
Muscular metastasis, a rare presentation of non-small-cell lung cancerAlbiruni Ryan Abdul Razak, Rajiv Chhabra, Andrew Hughes, et al.
Cancer|February 10, 2017
Determinants of the recommended phase 2 dose of molecular targeted agentsAaron R Hansen, Natalie Cook, Eitan Amir, et al.
Medscape Journal of Medicine|April 3, 2008
Tracheobronchial amyloidosis: utilization of radiotherapy as a treatment modalitySangeetha Poovaneswaran, Albiruni Ryan Abdul Razak, Hilmi Lockman, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|January 21, 2012
Prognostic and predictive value of CA-125 in the primary treatment of epithelial ovarian cancer: potentials and pitfallsIván Díaz-Padilla, Albiruni Ryan Abdul Razak, Lucas Minig, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 18, 2009
Extraosseous pericardial Ewing's sarcomaFathi Azribi, Albiruni Ryan Abdul Razak, Georgina Bough, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Lung Cancer (Amsterdam, Netherlands)|October 18, 2008
Carboplatin and pemetrexed in the management of malignant pleural mesothelioma: a realistic treatment option?Louise Li, Albiruni Ryan Abdul Razak, Andrew Hughes
Lung Cancer (Amsterdam, Netherlands)|October 9, 2007
Retreatment with pemetrexed-based chemotherapy in malignant pleural mesothelioma (MPM): a second line treatment optionAlbiruni Ryan Abdul Razak, Katy J Chatten, Andrew N Hughes
Therapeutic Advances in Medical Oncology|May 15, 2024
Clinical activity of pembrolizumab in refractory <i>MDM2</i>-amplified advanced intimal sarcomasMauricio Fernando Ribeiro, Elizabeth G Demicco, Albiruni Ryan Abdul Razak
The Cochrane Database of Systematic Reviews|March 18, 2011
Chemotherapy for malignant germ cell ovarian cancer in adult patients with early stage, advanced and recurrent diseaseAlbiruni Ryan Abdul Razak, Louise Li, Andrew Bryant, et al.
Journal of Neuro-Oncology|June 4, 2005
Medulloblastoma in two successive pregnanciesAlbiruni Ryan Abdul Razak, Qasiem Nasser, Patrick Morris, et al.
Medgenmed : Medscape General Medicine|December 20, 2007
Muscular metastasis, a rare presentation of non-small-cell lung cancerAlbiruni Ryan Abdul Razak, Rajiv Chhabra, Andrew Hughes, et al.
Cancer|February 10, 2017
Determinants of the recommended phase 2 dose of molecular targeted agentsAaron R Hansen, Natalie Cook, Eitan Amir, et al.
Medscape Journal of Medicine|April 3, 2008
Tracheobronchial amyloidosis: utilization of radiotherapy as a treatment modalitySangeetha Poovaneswaran, Albiruni Ryan Abdul Razak, Hilmi Lockman, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|January 21, 2012
Prognostic and predictive value of CA-125 in the primary treatment of epithelial ovarian cancer: potentials and pitfallsIván Díaz-Padilla, Albiruni Ryan Abdul Razak, Lucas Minig, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 18, 2009
Extraosseous pericardial Ewing's sarcomaFathi Azribi, Albiruni Ryan Abdul Razak, Georgina Bough, et al.
Pageof 2